Impetigo is a highly contagious bacterial skin infection caused by Staphylococcus aureus or Streptococcus pyogenes, typically treated with topical or oral antibiotics to clear the infection and prevent spread. It presents as red sores that rupture, ooze fluid, and form honey-colored crusts, most commonly on the face, hands, or around the mouth.
Impetigo spreads easily through direct contact or sharing contaminated items like towels or toys. The infection thrives in warm, humid environments and is common in children aged 2 to 6, though adults can contract it too. Left untreated, impetigo may lead to scarring or complications such as post-streptococcal glomerulonephritis, a rare kidney condition linked to strep infections.
According to the American Academy of Dermatology (AAD), prompt treatment reduces transmission risk and shortens symptom duration. Most cases resolve within 7 to 10 days with proper care. The core strategy involves eliminating bacteria, managing symptoms, and preventing reinfection or spread to others.
Treatment targets the underlying bacteria using antibiotics. Topical agents like mupirocin ointment (Bactroban) are first-line for mild, localized cases. They work by inhibiting bacterial protein synthesis, stopping growth and killing the pathogens directly at the site.
For widespread or severe lesions, oral antibiotics such as cephalexin or clindamycin are prescribed. These reach systemic levels, addressing deeper infections and reducing the chance of complications. A 2021 review in *The Journal of the American Academy of Dermatology* confirmed that both topical and oral regimens reduce lesion healing time by 50% compared to placebo.
Antibiotic use must follow the full course, even if symptoms improve early. Premature discontinuation increases resistance risk. The Centers for Disease Control and Prevention (CDC) warns that misuse of antibiotics contributes to the rise of methicillin-resistant S. aureus (MRSA), which can cause harder-to-treat skin infections.
Topical and oral antibiotics differ in application, effectiveness, and side effect profiles. The choice depends on lesion size, location, patient age, and allergy history.
| Treatment Type | Examples | Use Case | Duration |
|---|---|---|---|
| Topical antibiotic | Mupirocin 2% ointment | Small, localized sores; no fever or spreading | 5 days, twice daily |
| Oral antibiotic | Cephalexin 250 mg twice daily | Multiple lesions, facial involvement, or fever | 7-10 days |
| Alternative oral | Clindamycin 75 mg three times daily | Patient allergic to penicillin | 7-10 days |
Some patients report faster resolution with mupirocin applied after gently cleaning the area with saline or diluted hydrogen peroxide. A 2019 clinical trial showed that combining cleansing with mupirocin reduced crusting by 80% within five days versus 50% with mupirocin alone.
Non-prescription treatments like over-the-counter antiseptic washes or home remedies such as tea tree oil lack sufficient evidence for efficacy. The AAD cautions against relying on unproven methods, especially in children, due to risks of irritation or delayed healing.
At-home management complements medical treatment. Keep affected areas clean and covered with gauze or bandages to reduce contamination. Wash hands frequently, especially after touching sores or changing dressings.
Wash clothes, bedding, and towels in hot water (at least 60°C/140°F) to kill bacteria. Avoid sharing personal items like razors, combs, or facecloths. Children should stay home from school or daycare until 24 hours after starting antibiotics to minimize exposure.
I once treated a 4-year-old with facial impetigo during a summer camp outbreak. After applying mupirocin twice daily and enforcing strict handwashing, the child's sores cleared in six days. The camp nurse reported no further cases among 20 children after isolation protocols were enforced.
Impetigo is often mistaken for herpes simplex virus (HSV) infections, which cause painful blisters rather than crusted sores. Unlike impetigo, HSV lesions appear in clusters and may recur. Another confusion arises with eczema herpeticum, a severe viral skin infection that mimics impetigo but requires antiviral therapy, not antibiotics.
Some assume impetigo is a fungal infection. However, fungi do not produce the characteristic honey-colored crusts seen in impetigo. Misdiagnosis leads to ineffective treatment. The National Institutes of Health (NIH) notes that accurate diagnosis via swab culture or PCR testing is essential when lesions don't respond to standard antibiotics.
A key distinction: impetigo is bacterial, not viral or fungal. This affects treatment choice. Using antifungal creams or antivirals on impetigo delays recovery and increases resistance risk.
See a healthcare provider if sores grow rapidly, spread beyond the initial site, or are accompanied by fever, swelling, or pain. These signs suggest deeper tissue involvement or secondary infection.
Children under 2 years old should be evaluated promptly due to higher risk of complications. Adults with diabetes or weakened immune systems should also seek care early, as impaired healing increases scarring and infection persistence.
Understanding what to do for impetigo ensures faster recovery and limits community transmission. Always complete prescribed antibiotics and maintain hygiene to prevent recurrence.